Impaired Cerebrovascular Reactivity in Huntington's Disease

Suk Tak Chan1, Nathaniel D Mercaldo1, Kenneth K Kwong1

  • 1Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States.

Insights

Cerebrovascular reactivity (CVR) is impaired in Huntington's disease (HD) subjects, indicated by weaker blood-oxygen-level-dependent (BOLD) signal responses to carbon dioxide (CO2) challenges in specific brain regions. This suggests cerebrovascular dysfunction may contribute to early HD neuropathology.

Area of Science:

  • Neuroscience
  • Neurology
  • Cerebrovascular Research

Background:

  • Huntington's disease (HD) is linked to early neuronal loss, with growing evidence suggesting cerebrovascular dysfunction plays a role.
  • Cerebrovascular reactivity (CVR) assessment using functional magnetic resonance imaging (fMRI) with carbon dioxide (CO2) challenges is established for evaluating neurodegenerative disorders.

Purpose of the Study:

  • To investigate potential impairments in CVR in individuals with Huntington's disease (HD).
  • To explore the relationship between CVR alterations and early neuropathological changes in HD.

Main Methods:

  • Functional magnetic resonance imaging (fMRI) and a carbon dioxide (CO2) gas challenge were administered to 12 HD subjects and 11 healthy controls.
  • Hilbert Transform analysis quantified the cross-correlation and response delay between regional blood-oxygen-level-dependent (BOLD) signals and CO2 levels.

Main Results:

  • HD subjects exhibited weaker regional BOLD signal correlations with CO2 levels in multiple subcortical white matter areas compared to controls, even after age correction.
  • A delay in the BOLD signal response relative to CO2 was observed in areas overlapping with dilated perivascular spaces (PVS).

Conclusions:

  • Preliminary findings indicate cerebrovascular function alterations in HD.
  • These CVR impairments may represent a significant, previously underappreciated factor in the early neuropathology of Huntington's disease.